IL-10 controls cystatin C synthesis and blood concentration in response to inflammation through regulation of IFN regulatory factor 8 expression

Journal of Immunology

Volumn 186, Issue 6, 2011, Pages 3666-3673

  Xu, Yuekang ^a,b   Schnorrer, Petra ^a,b,e   Proietto, Anna ^a,b   Kowalski, Greg ^c   Febbraio, Mark A ^c   Acha Orbea, Hans ^d   Dickins, Ross A ^a,b   Villadangos, Jose A ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; REGULATORY MECHANISM;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; CYSTATIN C; DENDRITIC CELLS; DOWN-REGULATION; INFLAMMATION MEDIATORS; INTERFERON REGULATORY FACTORS; INTERLEUKIN-10; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC;

EID: 79953182318     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001934     Document Type: Article

References (47)

1. Bird, P. I., J. A. Trapani, and J. A. Villadangos. 2009. Endolysosomal proteases and their inhibitors in immunity. Nat. Rev. Immunol. 9: 871-882.
2. Georges, S., C. Ruiz Velasco, V. Trichet, Y. Fortun, D. Heymann, and M. Padrines. 2009. Proteases and bone remodelling. Cytokine Growth Factor Rev. 20: 29-41.
3. Liu, J., G. K. Sukhova, J. S. Sun, W. H. Xu, P. Libby, and G. P. Shi. 2004. Lysosomal cysteine proteases in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24: 1359-1366.
4. Latz, E. 2010. The inflammasomes: mechanisms of activation and function. Curr. Opin. Immunol. 22: 28-33.
5. Abrahamson, M., A. J. Barrett, G. Salvesen, and A. Grubb. 1986. Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J. Biol. Chem. 261: 11282-11289.
6. Alvarez-Fernandez, M., A. J. Barrett, B. Gerhartz, P. M. Dando, J. Ni, and M. Abrahamson. 1999. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J. Biol. Chem. 274: 19195-19203.
7. Shi, G. P., G. K. Sukhova, A. Grubb, A. Ducharme, L. H. Rhode, R. T. Lee, P. M. Ridker, P. Libby, and H. A. Chapman. 1999. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J. Clin. Invest. 104: 1191-1197.
8. Huh, C. G., K. Håkansson, C. M. Nathanson, U. P. Thorgeirsson, N. Jonsson, A. Grubb, M. Abrahamson, and S. Karlsson. 1999. Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. MP, Mol. Pathol. 52: 332-340.
9. Hansen, T., P. K. Petrow, A. Gaumann, G. Keyszer, R. Bräuer, and J. Kriegsmann. 2000. Synovial giant cells in rheumatoid arthritis: expression of cystatin C, but not of cathepsin B. Exp. Toxicol. Pathol. 52: 312-316.
10. Gressner, A. M., B. Lahme, S. K. Meurer, O. Gressner, and R. Weiskirchen. 2006. Variable expression of cystatin C in cultured trans-differentiating rat hepatic stellate cells. World J. Gastroenterol. 12: 731-738.
11. Kos, J., M. Krasovec, N. Cimerman, H. J. Nielsen, I. J. Christensen, and N. Brünner. 2000. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin. Cancer Res. 6: 505-511.
12. Koenig, W., D. Twardella, H. Brenner, and D. Rothenbacher. 2005. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin. Chem. 51: 321-327.
13. Werle, B., K. Sauckel, C. M. Nathanson, M. Bjarnadottir, E. Spiess, W. Ebert, and M. Abrahamson. 2003. Cystatins C, E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders. Biol. Chem. 384: 281-287.
14. Frendéus, K. H., H. Wallin, S. Janciauskiene, and M. Abrahamson. 2009. Macrophage responses to interferon-gamma are dependent on cystatin C levels. Int. J. Biochem. Cell Biol. 41: 2262-2269.
15. Verdot, L., G. Lalmanach, V. Vercruysse, J. Hoebeke, F. Gauthier, and B. Vray. 1999. Chicken cystatin stimulates nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages via cytokine synthesis. Eur. J. Biochem. 266: 1111-1117.
16. Sokol, J. P., and W. P. Schiemann. 2004. Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells. Mol. Cancer Res. 2: 183-195.
17. Staniforth, R. A., S. Giannini, L. D. Higgins, M. J. Conroy, A. M. Hounslow, R. Jerala, C. J. Craven, and J. P. Waltho. 2001. Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily. EMBO J. 20: 4774-4781.
18. Palsdottir, A., M. Abrahamson, L. Thorsteinsson, A. Arnason, I. Olafsson, A. Grubb, and O. Jensson. 1988. Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet 2: 603-604.
19. Mi, W., M. Pawlik, M. Sastre, S. S. Jung, D. S. Radvinsky, A. M. Klein, J. Sommer, S. D. Schmidt, R. A. Nixon, P. M. Mathews, and E. Levy. 2007. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models. Nat. Genet. 39: 1440-1442.
20. Kaeser, S. A., M. C. Herzig, J. Coomaraswamy, E. Kilger, M. L. Selenica, D. T. Winkler, M. Staufenbiel, E. Levy, A. Grubb, and M. Jucker. 2007. Cystatin C modulates cerebral beta-amyloidosis. Nat. Genet. 39: 1437-1439.
21. Abrahamson, M., I. Olafsson, A. Palsdottir, M. Ulvsbäck, A. Lundwall, O. Jensson, and A. Grubb. 1990. Structure and expression of the human cystatin C gene. Biochem. J. 268: 287-294. (Pubitemid 20193964)
22. El-Sukkari, D., N. S. Wilson, K. Hakansson, R. J. Steptoe, A. Grubb, K. Shortman, and J. A. Villadangos. 2003. The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation. J. Immunol. 171: 5003-5011.
23. Naik, S. H., A. I. Proietto, N. S. Wilson, A. Dakic, P. Schnorrer, M. Fuchsberger, M. H. Lahoud, M. O'Keeffe, Q. X. Shao, W. F. Chen, et al. 2005. Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174: 6592-6597. (Pubitemid 40705619)
24. Tamura, T., P. Thotakura, T. S. Tanaka, M. S. Ko, and K. Ozato. 2005. Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages. Blood 106: 1938-1947. (Pubitemid 41291704)
25. Séronie-Vivien, S., P. Delanaye, L. Piéroni, C. Mariat, M. Froissart, J. P. Cristol; SFBC "Biology of renal function and renal failure" working group. 2008. Cystatin C: current position and future prospects. Clin. Chem. Lab. Med. 46: 1664-1686.
26. Holtschke, T., J. Löhler, Y. Kanno, T. Fehr, N. Giese, F. Rosenbauer, J. Lou, K. P. Knobeloch, L. Gabriele, J. F. Waring, et al. 1996. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87: 307-317. (Pubitemid 26359008)
27. Kühn, R., J. Löhler, D. Rennick, K. Rajewsky, and W. Müller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274. (Pubitemid 23320290)
28. Mach, N., S. Gillessen, S. B. Wilson, C. Sheehan, M. Mihm, and G. Dranoff. 2000. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Res. 60: 3239-3246. (Pubitemid 30407923)
29. Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shortman. 2000. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164: 2978-2986. (Pubitemid 30148956)
30. Bedoui, S., S. Prato, J. Mintern, T. Gebhardt, Y. Zhan, A. M. Lew, W. R. Heath, J. A. Villadangos, and E. Segura. 2009. Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses. J. Immunol. 182: 4200-4207.
31. O'Keeffe, M., H. Hochrein, D. Vremec, I. Caminschi, J. L. Miller, E. M. Anders, L. Wu, M. H. Lahoud, S. Henri, B. Scott, et al. 2002. Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus. J. Exp. Med. 196: 1307-1319.
32. Steiner, Q. G., L. A. Otten, M. J. Hicks, G. Kaya, F. Grosjean, E. Saeuberli, C. Lavanchy, F. Beermann, K. L. McClain, and H. Acha-Orbea. 2008. In vivo transformation of mouse conventional CD8alpha+ dendritic cells leads to progressive multisystem histiocytosis. Blood 111: 2073-2082.
33. Xu, Y., Y. Zhan, A. M. Lew, S. H. Naik, and M. H. Kershaw. 2007. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J. Immunol. 179: 7577-7584.
34. Dickins, R. A., M. T. Hemann, J. T. Zilfou, D. R. Simpson, I. Ibarra, G. J. Hannon, and S. W. Lowe. 2005. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat. Genet. 37: 1289-1295.
35. Xu, Y., P. K. Darcy, and M. H. Kershaw. 2007. Tumor-specific dendritic cells generated by genetic redirection of Toll-like receptor signaling against the tumor-associated antigen, erbB2. Cancer Gene Ther. 14: 773-780.
36. Nutt, S. L., D. Metcalf, A. D'Amico, M. Polli, and L. Wu. 2005. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J. Exp. Med. 201: 221-231.
37. Aliberti, J., O. Schulz, D. J. Pennington, H. Tsujimura, C. Reis e Sousa, K. Ozato, and A. Sher. 2003. Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cells. Blood 101: 305-310.
38. Tamura, T., P. Tailor, K. Yamaoka, H. J. Kong, H. Tsujimura, J. J. O'Shea, H. Singh, and K. Ozato. 2005. IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J. Immunol. 174: 2573-2581. (Pubitemid 40279670)
39. Wilson, N. S., G. M. Behrens, R. J. Lundie, C. M. Smith, J. Waithman, L. Young, S. P. Forehan, A. Mount, R. J. Steptoe, K. D. Shortman, et al. 2006. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 7: 165-172.
40. Villadangos, J. A., M. Cardoso, R. J. Steptoe, D. van Berkel, J. Pooley, F. R. Carbone, and K. Shortman. 2001. MHC class II expression is regulated in dendritic cells independently of invariant chain degradation. Immunity 14: 739-749. (Pubitemid 32592421)
41. Schwartz, D. A., C. L. Wohlford-Lenane, T. J. Quinn, and A. M. Krieg. 1999. Bacterial DNA or oligonucleotides containing unmethylated CpG motifs can minimize lipopolysaccharide-induced inflammation in the lower respiratory tract through an IL-12-dependent pathway. J. Immunol. 163: 224-231.
42. Wilson, N. S., D. El-Sukkari, and J. A. Villadangos. 2004. Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 103: 2187-2195.
43. Endre, Z. H., and J. Westhuyzen. 2008. Early detection of acute kidney injury: emerging new biomarkers. Nephrology (Carlton) 13: 91-98. (Pubitemid 351229631)
44. Tailor, P., T. Tamura, H. C. Morse, III, and K. Ozato. 2008. The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse. Blood 111: 1942-1945. (Pubitemid 351451503)
45. Rosenbauer, F., K. Wagner, J. L. Kutok, H. Iwasaki, M. M. Le Beau, Y. Okuno, K. Akashi, S. Fiering, and D. G. Tenen. 2004. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat. Genet. 36: 624-630.
46. Hochrein, H., M. O'Keeffe, T. Luft, S. Vandenabeele, R. J. Grumont, E. Maraskovsky, and K. Shortman. 2000. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J. Exp. Med. 192: 823-833.
47. Kitamura, H., H. Kamon, S. Sawa, S. J. Park, N. Katunuma, K. Ishihara, M. Murakami, and T. Hirano. 2005. IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells. Immunity 23: 491-502. (Pubitemid 41587889)